Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cholecystokinin (CCK) is a peptide hormone produced by I-cells in the mucosal lining of the upper small intestine (duodenum and jejunum) and also by certain neurons in the brain. Its secretion is stimulated primarily by the presence of fats and proteins in the intestinal lumen. Upon release, CCK acts on its receptors (mainly cholecystokinin receptor 1, CCK1R) on the pancreas and gallbladder to stimulate the release of digestive enzymes and bile. It also slows gastric emptying, increases intestinal motility, and triggers signals of satiety to the brain. CCK also functions as a neuropeptide, influencing behavior and central nervous system signaling. The release mechanism is tightly regulated via nutrient sensing and neurohumoral pathways.
Drugs that mimic CCK stimulate gallbladder contraction and pancreatic secretion. CCK receptor antagonists block these processes and reduce GI motility or secretion.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cholecystokinin (CCK).